Skip to main content
. 2016 Dec 20;129(24):2913–2919. doi: 10.4103/0366-6999.195462

Table 1.

The 5-HT levels in serum, platelet lysate, and brain homogenate after saline and GFS treatments (pg/ml)

Items Saline treatment subgroup GFS treatment subgroup F P
Serum
 Controls 242.94 ± 32.00 289.09 ± 74.70 3.318 0.184
 MI 55.92 ± 11.58 365.16 ± 41.28 10.348 0.000
 Depression 74.63 ± 4.97 375.50 ± 35.90 16.165 0.000
 MI + depression 62.49 ± 10.20 391.66 ± 41.55 3.128 0.000
Platelet lysate
 Controls 80.38 ± 5.52 306.49 ± 24.91 9.805 0.000
 MI 52.25 ± 8.57 80.30 ± 0.85 16.600 0.002
 Depression 55.18 ± 4.85 302.10 ± 7.12 0.179 0.000
 MI + depression 60.78 ± 11.16 315.99 ± 18.99 0.870 0.000
Brain homogenate
 Controls 400.85 ± 47.67 342.71 ± 47.47 0.130 0.060
 MI 334.05 ± 57.49 265.01 ± 27.96 2.519 0.025
 Depression 376.26 ± 56.84 306.27 ± 47.73 0.634 0.044
 MI + depression 369.39 ± 95.62 347.65 ± 70.24 0.295 0.663

The data are shown as mean ± SE. n = 10 in each subgroup of control and depression groups, and n = 8 in each subgroup of MI and MI + depression groups. 5-HT: 5-hydroxytryptamine; MI: Myocardial infarction; GFS: Ginseng fruit saponins; SE: Standard error.